Pharma Journalist - Page 61 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Piramal Pharma Solutions Breaks Ground on $90M Expansion

AbbVie to Acquire Capstan Therapeutics, Advancing Immunology Innovation

FDA Approves Takeda’s GAMMAGARD LIQUID ERC, First Low-IgA Ready-to-Use Therapy

ProFound Therapeutics, Novartis Announce Multi-Year Cardiovascular Collaboration

Novartis Completes Acquisition of Regulus Therapeutics

Porton Advanced, EVA Pharma Sign MOU to Expand CAR T-Cell Therapy in MEA Region

Bayer Extends Partnership with Tsinghua University to Boost Pharma Research in China

FDA Expands GE HealthCare’s Vizamyl Indications for Enhanced Alzheimer’s Beta Amyloid Detection

FDA Approves Benlysta Autoinjector for Pediatric Lupus Nephritis

Gilead and Kymera Partner on Novel Oral CDK2 Degraders in Exclusive License Deal